Health AI Register Logo
ProductsPlatformsCompaniesNewsContact
ProductsCT Image Analysis Software II - Coronary Plaque

Vendor source

Reviewed 11 May 2026

Completeness Strong (64%)

CT Image Analysis Software II - Coronary Plaque

United Imaging Intelligence

The CT Coronary Plaque application is intended to assist in detecting and evaluating plaques found in cardiac CT images of adult patients. It provides segmentation results of the detected plaques, multiple reconstructed images and a series of parameters, facilitating radiologists to confirm or dismiss the software detected plaques.

No papers to support — we monitor for new evidence.

CT Image Analysis Software II - Coronary Plaque

Key Features

  • Coronary lesion detection
  • High risk plaque classification
  • Plaque analysis
  • Plaque detection
  • Reconstructed images (MPR/VR/MIP/Probe/CPR/SCPR)
  • Segmentation and 3D reconstruction of heart and coronary arteries
  • Stenosis detection

General Information

Product name

CT Image Analysis Software II - Coronary Plaque

Modality

CT

Main task

Detection

Subspeciality

Cardiac

Disease targeted

Coronary lesions, stenosis, coronary plaque

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIa

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Adult

Input

Cardiac CT

Input format

DICOM

Output

Reconstructed images (MPR/VR/MIP/Probe/CPR/SCPR), segmentation of heart and coronary arteries, lesion list, table and graph of quantified values

Output format

Not specified

Integration

Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, docker)

Trigger for analysis

Automatically, right after the image acquisition

Processing time

Not specified

Population

Adults (18–120). Contraindicated in line with coronary CTA: iodine allergy, severe heart/kidney/lung dysfunction, severe arrhythmia, complex congenital heart disease, implanted pacemakers or defibrillators, and artificial heart valves. Use with caution in cases of poor image quality affecting interpretation (e.g., motion, misregistration, beam-hardening, blooming, or interpolation artifacts), excessive image noise, or poor contrast filling.

Market Presence

On market since

08-2025

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

One-time license fee, Pay-per-use, Subscription

Based on

Number of analyses, Number of installations, Number of users

Source: Vendor | First published: Oct 13, 2025 | Last updated: May 11, 2026